Suppr超能文献

肥厚型心肌病延迟钆增强的定量分析:钆布醇与钆喷酸葡胺在心肌纤维化诊断效能上的比较

Quantitative analysis of late gadolinium enhancement in hypertrophic cardiomyopathy: comparison of diagnostic performance in myocardial fibrosis between gadobutrol and gadopentetate dimeglumine.

作者信息

Liu Dongting, Ma Xiaohai, Liu Jiayi, Zhao Lei, Chen Hui, Xu Lei, Sun Zhonghua, Fan Zhanming

机构信息

Department of Radiology, Beijing Anzhen Hospital, Capital Medical University, No. 2, Anzhen Road, Chaoyang District, Beijing, 100029, China.

Department of Medical Radiation Sciences, Curtin University, Perth, 6102, Australia.

出版信息

Int J Cardiovasc Imaging. 2017 Aug;33(8):1191-1200. doi: 10.1007/s10554-017-1101-7. Epub 2017 Mar 13.

Abstract

The purpose of this study was to compare different semi-automated late gadolinium enhancement (LGE) quantification techniques using gadobutrol and gadopentetate dimeglumine contrast agents with regard to the diagnosis of fibrotic myocardium in patients with hypertrophic cardiomyopathy (HCM). Thirty patients with HCM underwent two cardiac MRI protocols with use of gadobutrol and gadopentetate dimeglumine. Contrast-to-noise ratio (CNR) between LGE area and remote myocardium (CNRremote), between LGE area and left ventricular blood pool (CNRpool), and signal-to-noise ratio (SNR) in LGE were compared. The presence and quantity of LGE were determined by visual assessment. With signal threshold versus reference mean (STRM) based thresholds of 2 SD, 5 SD, and 6 SD above the mean signal intensity (SI) of reference myocardium, the full-width at half-maximum (FWHM) technique was used. The volume and segments of the LGE area were compared between the two types of contrast agents. LGE was present in 26 of 30 (86.6%) patients in both protocols. The CNRremote of fibrotic myocardium in gadobutrol and gadopentetate dimeglumine agents was 26.82 ± 14.24 and 21.46 ± 10.59, respectively (P < 0.05). The CNRpool was significantly higher in gadobutrol (9.32 ± 7.64 vs. 6.39 ± 6.11, P < 0.05). The SNR was higher in gadobutrol (33.36 ± 14.35 vs. 27.53 ± 10.91, P < 0.05). The volume of scar size in MR images acquired with gadobutrol were significantly higher than those with gadopentetate dimeglumine (P < 0.05), and the STRM of 5 SD technique showed the greatest agreement with visual assessment (ICC = 0.99) in both examinations. There was no significant difference in fibrotic segments of the fibrotic myocardium in the LGE area (P < 0.05). This study proved that the Gadobutrol was an effective contrast agent for LGE imaging with superior delineation of fibrotic myocardium as compared to gadopentetate dimeglumine. The 5 SD technique yields the closest approximation of the extent of LGE identified by visual assessment.

摘要

本研究的目的是比较使用钆布醇和钆喷酸葡胺造影剂的不同半自动延迟钆增强(LGE)定量技术,以诊断肥厚型心肌病(HCM)患者的纤维化心肌。30例HCM患者接受了使用钆布醇和钆喷酸葡胺的两种心脏MRI检查方案。比较了LGE区域与远隔心肌之间的对比噪声比(CNRremote)、LGE区域与左心室血池之间的对比噪声比(CNRpool)以及LGE中的信噪比(SNR)。通过视觉评估确定LGE的存在和数量。基于信号阈值与参考均值(STRM),以高于参考心肌平均信号强度(SI)2 SD、5 SD和6 SD的阈值,采用半高宽(FWHM)技术。比较了两种造影剂之间LGE区域的体积和节段。两种检查方案中,30例患者中有26例(86.6%)存在LGE。钆布醇和钆喷酸葡胺造影剂中纤维化心肌的CNRremote分别为26.82±14.24和21.46±10.59(P<0.05)。钆布醇的CNRpool显著更高(9.32±7.64对6.39±6.11,P<0.05)。钆布醇的SNR更高(33.36±14.35对27.53±10.91,P<0.05)。使用钆布醇采集的MR图像中瘢痕大小的体积显著高于使用钆喷酸葡胺的图像(P<0.05),并且在两次检查中,5 SD技术的STRM与视觉评估的一致性最高(ICC = 0.99)。LGE区域中纤维化心肌的纤维化节段无显著差异(P<0.05)。本研究证明,与钆喷酸葡胺相比,钆布醇是一种有效的LGE成像造影剂,能更好地勾勒出纤维化心肌。5 SD技术得出的结果与通过视觉评估确定的LGE范围最接近。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验